Ideal Power Inc. (IPWR) - Q2 2025 Filing Summary
Business Context and Reporting Period
This summary covers the Unaudited Condensed Financial Statements for Ideal Power Inc. for the quarterly period ended June 30, 2025. Ideal Power is a smaller reporting company focused on the development and commercialization of its Bidirectional bipolar junction TRANsistor (B-TRAN®) solid-state switch technology. The company operates as a single segment and is currently in the commercialization phase of its SymCool® Power Module and SymCool® IQ Intelligent Power Module products.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|
| Revenue | $1,275 | $13,278 | $80,070 |
| Net Loss | $(3,036,765) | $(5,739,789) | $(5,131,691) |
| Loss Per Share (Basic/Diluted) | $(0.33) | $(0.63) | $(0.69) |
| Cash and Cash Equivalents | $11,105,553 (as of June 30, 2025) | ||
| Net Working Capital | $10.5 million (as of June 30, 2025) | ||
| Debt | No outstanding debt | ||
| Operating Cash Flow (YTD) | $(4,425,301) used |
Material Changes vs. Prior Period
- Revenue Decline: Revenue for the six months ended June 30, 2025, dropped significantly to $13,278 compared to $80,070 in the same period in 2024. The prior year included revenue from the completion of the second phase of a development agreement with Stellantis, whereas current revenue is derived from initial low-volume product shipments and a first design win for solid-state circuit breakers (SSCB).
- Increased Operating Loss: Net loss for the six months ended June 30, 2025, increased by 12% to $5.74 million compared to $5.13 million in 2024. This was driven by higher Research and Development (R&D) expenses.
- R&D Expense Growth: R&D expenses increased by 18% year-over-year to $3.47 million for the six-month period. This increase was primarily due to higher semiconductor fabrication costs ($335,220) and personnel costs ($264,645), partially offset by lower packaging and prototyping costs.
- Cash Position: Cash and cash equivalents decreased by approximately $4.7 million during the first half of 2025, reflecting the net cash used in operating activities. Unlike the prior year, there were no significant financing proceeds from stock offerings in the first half of 2025.
Outlook, Management Commentary, and Risks
- Commercialization Progress: Management reports the completion of deliverables for its first design win with a major circuit protection equipment manufacturer in Q1 2025, three months ahead of schedule. Commercial sales are expected later in 2025.
- Stellantis Partnership: The company successfully completed the second phase of its development agreement with Stellantis for a custom B-TRAN® power module for EV drivetrain inverters. The program is transitioning to the production team for extensive testing to meet automotive certification standards.
- Liquidity: Management believes current cash reserves of $11.1 million are sufficient to meet liquidity needs for at least the next twelve months. However, the company expects increased cash outflows from operating activities in the second half of 2025 as development and commercialization efforts continue.
- Risks: Key risks include the company's history of losses, dependence on future financing, the time required for third-party design wins and certification, and the ability to scale production to achieve positive gross margins. The company currently operates with negative gross margins due to low-volume shipments.
Investor Verification Checklist
- Runway Validation: Verify the $11.1 million cash balance against projected burn rates to confirm the 12-month liquidity runway assertion.
- Design Win Conversion: Monitor announcements regarding the conversion of the Q1 2025 SSCB design win into actual commercial revenue orders in the second half of 2025.
- Stellantis Timeline: Track the progress of the Stellantis program as it moves to the production testing phase; delays in automotive certification could impact long-term revenue projections.
- Financing Needs: Assess the likelihood of future equity dilution or debt financing requirements if commercialization timelines extend beyond the current cash runway.
- Gross Margin Trajectory: Review future quarterly reports for evidence of gross margin improvement as production volumes increase beyond the current prototype/low-volume stage.